Your browser doesn't support javascript.
loading
"The medications are the decision-makers…" Making reproductive and medication use decisions among female patients with rheumatoid arthritis: a constructivist grounded theory.
Rebic, Nevena; Munro, Sarah; Garg, Ria; Hazlewood, Glen; Amiri, Neda; Baldwin, Corisande; Ensworth, Stephanie; Proulx, Laurie; De Vera, Mary A.
Afiliação
  • Rebic N; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Munro S; Arthritis Research Centre of Canada, Vancouver, BC, Canada.
  • Garg R; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada.
  • Hazlewood G; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada.
  • Amiri N; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada.
  • Baldwin C; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Ensworth S; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada.
  • Proulx L; Arthritis Research Centre of Canada, Vancouver, BC, Canada.
  • De Vera MA; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Arthritis Res Ther ; 24(1): 31, 2022 01 22.
Article em En | MEDLINE | ID: mdl-35065668
OBJECTIVE: To examine how female patients with RA form decisions about having children, pregnancy, and medication use. METHODS: We employed a constructivist grounded theory design and recruited female participants who are 18 years or older, have a rheumatologist-confirmed RA diagnosis, live in Canada, and are able to communicate in English or French. We collected data through semi-structured individual and focus group interviews using telephone or video conferencing technology. Data collection and analysis were iterative, employed theoretical sampling, reflexive journaling, and peer debriefing, and culminated in a theoretical model. RESULTS: We recruited 21 participants with a mean age of 34 years and median 10 years since RA diagnosis. Overall, 33% had never been pregnant, 57% had previously been pregnant, and 10% were pregnant at the time of interview. Of those who had experienced pregnancy, 64% had at least one pregnancy while diagnosed with RA and of those, 56% used DMARD(s) during a pregnancy. We constructed a patient-centred framework depicting the dynamic relationships between 4 decision-making processes-(1) using medications, (2) having children, (3) planning pregnancy, and (4) parenting-and the substantial impact of healthcare providers on patients' experiences making these decisions. These processes were further influenced by participants' intersecting identities and contextual factors, particularly attitudes towards health and medications, disease onset and severity, familial support system, and experiences interacting with the healthcare system. CONCLUSION: Our framework provides insight into how patients make reproductive decisions in the context of managing RA and the opportunities for providers to support them at each decision-making process. A patient-centred care approach is suggested to support female patients with RA in making reproductive and medication choices aligning with their individual desires, needs, and values.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Child / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Child / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article